Solid Tumor Clinical Trials

A listing of Solid Tumor medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 879 clinical trials
  • 0 views
  • 24 Apr, 2022
  • 1 location
A Phase 1 Study of BPI-28592 in Subjects With Advanced Solid Tumors

This is an open-labe Phase I study of BPI-28592 for the treatment of patients with solid tumors

solid tumor
  • 0 views
  • 19 Apr, 2022
A Study of EMB-02 in Participants With Advanced Solid Tumors

The primary purpose of this study is to identify the recommended Phase 2 dose(s) (RP2Ds) and schedule assessed to be safe for EMB-02 and to characterize the safety and tolerability of EMB-02 at the RP2Ds. Pharmacokinetics (PK), immunogenicity, and the anti-tumor activity of EMB-02 will also be assessed.

  • 0 views
  • 24 Apr, 2022
  • 6 locations
A Phase I Study of JS108 in Patients With Advanced Solid Tumors

This is a phase I, open-label, first-in-human clinical study designed to evaluate the safety, tolerability, PK profile and efficacy of JS108 for patients with advanced solid tumors. This study

  • 0 views
  • 19 Apr, 2022
  • 3 locations
First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

recurrent solid tumors or metastatic solid tumors where curative or standard treatment options have been exhausted

breast cancer
carcinoma
primary cancer
  • 0 views
  • 26 Apr, 2022
  • 1 location
  • 18 views
  • 29 Apr, 2022
  • 2 locations
A Study to Evaluate YH001 in Subjects With Advanced Solid Tumors

(RP2D) of YH001 in subjects with advanced solid tumors.

  • 0 views
  • 12 May, 2022
  • 1 location
  • 50 views
  • 02 May, 2022
  • 4 locations
A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

administered orally daily. This study consists of Phase 1 and Phase 2 components in subjects with advanced solid tumors and lymphoma who have progressed despite having standard therapy or for which no standard

  • 0 views
  • 09 May, 2022
  • 2 locations
Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors

This is a first-in-human (FIH), multicenter, open-label, uncontrolled, Phase 1/2a study with dose escalation in patients with advanced solid tumors (Part 1) and cohorts of up to 15 patients per

  • 0 views
  • 10 May, 2022
  • 1 location